Results 91 to 100 of about 112,825,263 (146)

No Simple Fluke: Schistosomiasis as an Emerging Regulator of Haematopoiesis

open access: yesParasite Immunology, Volume 48, Issue 7, July 2026.
ABSTRACT Schistosomiasis, or bilharzia, is a highly prevalent water‐borne helminth infection that accounts for an estimated 1.5–1.7 billion disability‐adjusted life years lost annually. Pathology driven by adult worms and eggs is accompanied by robust immunomodulation in the human host. Protective responses may promote worm elimination, limit bystander
Shinjini Chakraborty
wiley   +1 more source

Control of poorly immunogenic tumors with systemic STING agonist‐loaded liposomes targeting cross‐presenting dendritic cells

open access: yesClinical &Translational Immunology, Volume 15, Issue 6, 2026.
WH‐peptide‐functionalised liposomes encapsulating STING or RIG‐I agonists target intra‐tumoral Clec9A+ cDC1 and pDC, triggering release of type 1 IFN, presentation of CD4 and CD8 endogenous tumor epitopes, expansion of CTL with help from CD4 T cells in spleen, and tumor cell killing.
Bijun Zeng   +11 more
wiley   +1 more source

Managing Autofluorescence in Spectral Flow Cytometry for Macrophage Identification in the Liver

open access: yesEuropean Journal of Immunology, Volume 56, Issue 6, June 2026.
Autofluorescence in liver tissue is heterogeneous and dynamically altered during metabolic liver disease, complicating spectral flow cytometry analysis. We provide a structured framework for identifying and handling condition‐dependent autofluorescence, demonstrating that inadequate autofluorescence correction biases macrophage quantification and ...
Sabine Daemen   +5 more
wiley   +1 more source

Nanobiocatalysts: Potential Applications in Biofuel Production and Biotransformation

open access: yesCarbon Neutralization, Volume 5, Issue 3, May 2026.
The application of nanobiocatalysts in the field of biofuel production and the biotransformation of substrate were reviewed. Further, the possible research gaps in the field of biofuel and value‐added compound production and a possible way to enhance the application of nanobiocatalyst in future development are highlighted.
Preethi Muthu   +4 more
wiley   +1 more source

Evaluation of the podoplanin/C-type lectin-like receptor-2 (CLEC-2) pathway as a mediator of platelet and coagulation activation in sickle cell disease

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Sickle cell disease (SCD) is a condition characterized by a prothrombotic state attributed to the simultaneous activation of hemostasis and innate immunity, referred to as thromboinflammation.
Ivanio Teixeira Borba-Junior   +8 more
doaj   +1 more source

Pragmatic Clinical Trial of Fostamatinib as Second‐Line Therapy in Adult Patients With Immune Thrombocytopenia and Insufficient Response to Prior Therapy: The Fostamatinib FORTE Trial

open access: yes
eJHaem, Volume 7, Issue 4, August 2026.
Amber Afzal   +8 more
wiley   +1 more source

C-type lectin-like receptor 2 (CLEC-2)-dependent DC migration is controlled by tetraspanin CD37

open access: yes, 2017
Cell migration is central to evoke a potent immune response. Dendritic cell (DC) migration to lymph nodes is dependent on the interaction of C-type lectin-like receptor 2 (CLEC-2) expressed by DCs, with podoplanin expressed by lymph node stromal cells ...
Carl G Figdor   +12 more
core   +1 more source

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

open access: yesPLoS ONE, 2013
The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2.
Satoshi Takagi   +7 more
doaj   +1 more source

Antibody-mediated depletion of human CLEC-2 in a novel humanised mouse model

open access: yes, 2021
Platelet C-type lectin-like receptor 2 (CLEC-2) has been proposed as a potential anti-thrombotic target as genetic or antibody-mediated receptor deficiency prevents occlusive thrombus formation in mice.
Di, Ying   +21 more
core   +1 more source

Level of podoplanin expression in HeLa cells and the purity of the Fc-CLEC-2 fusion protein.

open access: yes, 2019
(A) Western blot analysis of podoplanin expression levels in pod-HeLa cells, parental HeLa cells, and TE11 cells. Triton X-100-soluble fractions from the indicated cells (4 μg or 20 μg) were analyzed by western blot for podoplanin expression levels.
Yusuke Suzuki (525707)   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy